Article
Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites.
The Biochemical journal - 29 Jan 2021
Nirujogi Raja S, Tonelli Francesca, Taylor Matthew, Lis Pawel, Zimprich Alexander, Sammler Esther, Alessi Dario R
Abstract excerpt
Mutations that increase the protein kinase activity of LRRK2 are one of the most common causes of familial Parkinson's disease. LRRK2 phosphorylates a subset of Rab GTPases within their Switch-II motif, impacting interaction with effectors. We describe and validate a new, multiplexed targeted mass spectrometry assay to quantify endogenous levels of LRRK2-phosphorylated Rab substrates (Rab1, Rab3, Rab8, Rab10,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
